Unexplained weight loss (UWL) is a frequent clinical challenge for physicians. It is often associated with underlying serious conditions, including malignancies, gastrointestinal disorders, and endocrine abnormalities. This article aims to provide a comprehensive approach to the evaluation and management of UWL in clinical practice.
UWL can be a manifestation of multiple pathologies. The most common causes include malignancies, chronic infections, gastrointestinal disorders, and endocrine abnormalities. The pathophysiology of UWL is multifactorial and often involves a combination of reduced caloric intake, increased metabolic rate, and malabsorption.
A thorough history and physical examination are essential in the assessment of UWL. The history should focus on the duration of weight loss, associated symptoms, and risk factors for specific diseases. Physical examination should include a comprehensive systemic evaluation to identify any signs of underlying disease.
The diagnostic approach to UWL should be guided by the clinical assessment. Initial investigations may include a complete blood count, metabolic panel, thyroid function tests, and imaging studies. Further investigations should be directed by the initial findings and may include endoscopy, biopsy, or specialized imaging studies.
Management of UWL is primarily directed towards treating the underlying cause. Nutritional support and symptom management are also important aspects of patient care. Early diagnosis and treatment can significantly improve patient outcomes.
UWL is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations are crucial in identifying the underlying cause. Timely diagnosis and management can significantly improve patient outcomes and quality of life.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation